Making blood on demand: How far have we come?
The reconstitution of the blood system in humans holds great therapeutic potential to treat many disorders, like blood cancers, sickle-cell anemia and others.
Scientists discover a new mechanism in childhood kidney cancer
As an embryo develops, its cells must learn what to do with the thousands of genes theyve been equipped with.
Advances in production of retinal cells for treating blindness
Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.
Delivery of healthy donor cells key to correcting bone disorder, researchers find
Osteogensis imperfecta (OI) is a group of genetic disorders that mainly affect the bone. Patients with OI have bones that break easily, sometimes with no apparent cause.
New stem cell discovery could accelerate MND research
The discovery, made by groups at the University of St Andrews and the University of Edinburgh, shows that “glial cells", which normally support neurons throughout the brain and spinal cord, become damaging to motor neurons in Motor Neuron Disease (MND).
Researchers develop more efficient approach to create mouse models
Genetically engineered mouse models are often used by scientists to study how the addition, deletion or mutation of genes affects the development of disease and effects of drugs.
Scientists find easier way to harvest healing factors from adult stem cells in the lab
A research team at Nanyang Technological University, Singapore (NTU Singapore) has found an easier way to harvest healing factors—molecules that promote tissue growth and regeneration—from adult stem cells.
Scientists develop new method for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St.Petersburg Polytechnic University (SPbPU) together with their colleagues developed a method of targeted drug delivery to cancer cells.
By fighting the direction of the blood flow, white blood cells forge a faster route to battle infections
When the immune system detects a foreign pathogen, a cascade of chemical signals call white blood cells to the scene.
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19